• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MRI boosts myocardial infarction assessment

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 1
Volume 32
Issue 1

Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.

Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.

“Non–contrast-enhanced MRI alone is not sufficient for accurate diagnosis of acute MI,” said principal investigator Dr. Yoko Mikami, a radiologist at Tsu City's Mie University Hospital.

Mikami and colleagues prospectively enrolled 37 patients diagnosed with acute myocardial infarction. Patients underwent a protocol including T2-weighted and late-enhanced MRI about five days after the onset of acute myocardial infarction. The investigators found that T2 imaging accurately pinned down areas of microvascular obstruction, which strongly correlate with post-MI hemorrhagic infarction.

The findings appeared in the October issue of the American Journal of Roentgenology.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.